Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia

Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice

(2011) Z. Cheng et al.   BLOOD

Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Levels

(2010)   ARCHIVES OF INTERNAL MEDICINE

Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B12vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors

(2010)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment

(2010) Kenneth N. Maclean et al.   MOLECULAR GENETICS AND METABOLISM

Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment

(2010) Kenneth N. Maclean et al.   MOLECULAR GENETICS AND METABOLISM

Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention

(2010) Meng Lee et al.   STROKE

Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis

(2009) April P. McDonald et al.   THROMBOSIS RESEARCH

Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia

(2008) Sanjana Dayal et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes

(2008) Sanjana Dayal et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Mouse models of cystathionine β-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia

(2008) Sapna Gupta et al.   FASEB JOURNAL